Skip to main contentSkip to navigation
Sirius Investors
Reviv3 Procare Company

Reviv3 Procare Company

RVIV
OTCConsumer Defensive

Reviv3 Procare Company (RVIV) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Reviv3 Procare Company's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
0.00
Strong
WeakModerateStrong
P/B Ratio
8.88
Weak
WeakModerateStrong
Earnings Yield
0.00%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
-
No data
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2025
Revenue Growth
-100.00%
Weak
WeakModerateStrong
Net Income Growth
-
No data
EPS Growth
-
No data

Efficiency & Liquidity

2025
Current Ratio
3.76
Strong
WeakModerateStrong
Quick Ratio
2.73
Strong
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
2.25%
Weak
WeakModerateStrong
EV / Free Cash Flow
42.30x
Weak
WeakModerateStrong
Net Debt / EBITDA
-1.09x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-
No data
Return on Invested Capital
-
No data
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for RVIV.

View Financial Statements